The REVEAL registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension

Chest

Volumn 141, Issue 2, 2012, Pages 354-362

  Benza, Raymond L ^a   Gomberg Maitland, Mardi ^b   Miller, Dave P ^c   Frost, Adaani ^d   Frantz, Robert P ^e   Foreman, Aimee J ^c   Badesch, David B ^f   McGoon, Michael D ^e  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^c ICON Late Phase and Outcomes Research   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e MAYO CLINIC   (United States)

^f UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALGORITHM; ARTICLE; CALCULATION; CALIBRATION; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; REGISTER; RISK ASSESSMENT; SURVIVAL; VALIDATION STUDY; WALKING; WORLD HEALTH ORGANIZATION;

EID: 84863011141     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-0676     Document Type: Article

References (22)

1. Champion HC, Michelakis ED, Hassoun PM. Comprehensive invasive and noninvasive approach to the right ventricle-pulmonary circulation unit: state of the art and clinical and research implications. Circulation. 2009;120(11):992-1007.
2. Escribano Subias P, Barberà Mir JA, Suberviola V. Current diagnostic and prognostic assessment of pulmonary hypertension. Rev Esp Cardiol. 2010;63(5):583-596.
3. Frost AE, Badesch DB, Barst RJ, et al. The changing picture of pulmonary arterial hypertension patients in the United States: how the REVEAL registry differs from historic and non-US contemporary registries. Chest. 2011;139(1):128-137.
4. McGoon MD, Krichman A, Farber HW, et al. Design of the REVEAL registry for US patients with pulmonary arterial hypertension. Mayo Clin Proc. 2008;83(8):923-931.
5. Benza RL, Miller DP, Gomberg-Maitland M, et al. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation.2010;122(2):164-172.
6. Suissa S. Immortal time bias in observational studies of drug effects. Pharmacoepidemiol Drug Saf. 2007;16(3):241-249. (Pubitemid 46431687)
7. Pencina MJ, D'Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med. 2004;23(13):2109-2123. (Pubitemid 38968032)
8. Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med.1987;107(2):216-223. (Pubitemid 17137857)
9. D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med. 1991;115(5):343-349.
10. Rich S, Rubin L, Walker AM, Schneeweiss S, Abenhaim L. Anorexigens and pulmonary hypertension in the United States: results from the surveillance of North American pulmonary hypertension. Chest. 2000;117(3):870-874. (Pubitemid 30152231)
11. Stricker H, Domenighetti G, Popov W, et al Swiss Group for Severe Pulmonary Hypertension. Severe pulmonary hypertension: data from the Swiss Registry. Swiss Med Wkly.2001;131(23-24):346-350. (Pubitemid 32666249)
12. Humbert M, Sitbon O, Chaouat A, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med. 2006;173(9):1023-1030.
13. Walker AM, Langleben D, Korelitz JJ, et al. Temporal trends and drug exposures in pulmonary hypertension: an American experience. Am Heart J. 2006;152(3):521-526. (Pubitemid 44233427)
14. Jing ZC, Xu XQ, Han ZY, et al. Registry and survival study in Chinese patients with idiopathic and familial pulmonary arterial hypertension. Chest. 2007;132(2):373-379.
15. Thenappan T, Shah SJ, Rich S, Gomberg-Maitland M. A USA-based registry for pulmonary arterial hypertension: 1982-2006. Eur Respir J. 2007;30(6):1103-1110. (Pubitemid 351194756)
16. Humbert M, Sitbon O, Chaouat A, et al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation. 2010;122(2):156-163.
17. Thenappan T, Shah SJ, Rich S, Tian L, Archer SL, Gomberg- Maitland M. Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation. Eur Respir J.2010;35(5):1079-1087.
18. McLaughlin VV, Suissa S. Prognosis of pulmonary arterial hypertension: the power of clinical registries of rare diseases. Circulation. 2010;122(2):106-108.
19. Levy WC, Mozaffarian D, Linker DT, et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation. 2006;113(11):1424-1433. (Pubitemid 43739439)
20. Aaronson KD, Schwartz JS, Chen TM, Wong KL, Goin JE, Mancini DM. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation.1997;95(12):2660-2667. (Pubitemid 27255495)
21. Kane GC, Maradit-Kremers H, Slusser JP, Scott CG, Frantz RP, McGoon MD. Integration of clinical and hemodynamic parameters in the prediction of long-term survival in pulmonary arterial hypertension. Chest. 2011;139(6):1285-1293.
22. Lee KL, Pryor DB, Harrell FE Jr, et al. Predicting outcome in coronary disease. Statistical models versus expert clinicians. Am J Med. 1986;80(4):553-560. (Pubitemid 16035569)